Dr. David Bowtell
Peter MacCallum Cancer Centre, Melbourne, Australia
What determines ovarian cancer patient response to treatment and survival?

Dr. Denise Connolly
Fox Chase Cancer Center
Modeling Human Epithelial Ovarian Cancer in Mice by Alteration of Expression of the BRCA1 and/or p53 Genes

Dr. Mary B. Daly
Fox Chase Cancer Center
Assessing and Reducing Familial Ovarian Cancer Risk

Dr. Charles Drescher
Fred Hutchinson Cancer Research Center
Targeting Cell Surface Proteins in Molecular Photoacoustic Imaging to Detect Ovarian Cancer Early

Dr. Martin McIntosh
Fred Hutchinson Cancer Research Center
Identifying Autoantibody Biomarkers Derived from Cancer-Specific Splicing and Validating Them in Preclinical and Occult Ovarian Cancer Plasma Samples

Drs. Santo Nicosia and Patricia Kruk
University of South Florida
Urinary Biomarkers for Ovarian Cancer

The DOD Ovarian Cancer Academy Video
Dr. Michael Seiden, Fox Chase Cancer Center
Dr. Patricia Donahoe, Massachusetts General Hospital
Dr. Ronald Alvarez, University of Alabama at Birmingham
Dr. Panos Konstantinopoulos, Beth Israel Deaconess Medical Center
Dr. Rugang Zhang, The Wistar Institute
The Ovarian Cancer Academy: Training a New Generation

Dr. Ie-Ming Shih and Dr. Robert Kurman
Johns Hopkins University
Prevention of Ovarian High-Grade Serous Carcinoma by Elucidating Its Early Changes

Dr. Elizabeth Swisher
University of Washington
Premalignant Genetic and Epigenetic Alterations in Tubal Epithelium from Women with BRCA1 Mutations